Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Foreign Drug Makers To Cut Staffs Through India Sales Reps

This article was originally published in PharmAsia News

Executive Summary

About 10 foreign drug makers are cutting back on their sales forces in India by as many as 200 representatives as part of global reduction of expenses. In India, most of the companies face union laws and are attempting to reduce staff by various techniques, such as changing job titles. The cuts are believed taking place in India because the country has price controls that reduce the productivity level of sales representatives. The move by multinationals is the opposite of Indian pharmas, which are hiring as many sales people as they can attract. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts